ResearcherKeio UniversityActive in the last 2 years
Takanori Kanai∥
Matched on ORCID iD 0000-0002-1466-4532; OpenAlex author ID A5035900623. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 16
2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 5
- Clinical utility of comprehensive genomic profiling for advanced pancreatic cancer: insights from real-world data analysis. Co-author DOI 10.1007/s10147-025-02713-5↗
- Wnt-deficient and hypoxic environment orchestrates squamous reprogramming of human pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41556-024-01498-5↗
- Endoscopic Ultrasound-Guided Sampling for Personalized Pancreatic Cancer Treatment. Last author DOI 10.3390/diagnostics11030469↗
- Post-progression survival following second-line chemotherapy in patients with advanced pancreatic cancer previously treated with gemcitabine: a meta-analysis. Co-author DOI 10.1007/s10637-018-0589-6↗
- Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: meta-analysis of postprogression survival for first-line chemo… Last author DOI 10.1007/s00280-017-3263-3↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yasuo Hamamoto · 3 shared papers, 2017–2025 · strength 0.37
- Paper Clinical utility of comprehensive genomic profiling for advanced pancreatic cancer: insights from real-world data analy… DOI 10.1007/s10147-025-02713-5↗
- Paper Post-progression survival following second-line chemotherapy in patients with advanced pancreatic cancer previously tre… DOI 10.1007/s10637-018-0589-6↗
- Paper Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: meta-analysis of postp… DOI 10.1007/s00280-017-3263-3↗
- Hideyuki Hayashi · 2 shared papers, 2021–2025 · strength 0.34
- Eisuke Iwasaki · 2 shared papers, 2021–2024 · strength 0.27
- Hiroki Tamagawa · 2 shared papers, 2021–2024 · strength 0.27
- Eiichiro So · 1 shared paper, 2025 · strength 0.22
- Hiroshi Nishihara · 1 shared paper, 2025 · strength 0.22
- Ken Sasai · 1 shared paper, 2024 · strength 0.15
- Toshiro Sato · 1 shared paper, 2024 · strength 0.15
- Minoru Kitago · 1 shared paper, 2024 · strength 0.15
- Hiroshi Seno · 1 shared paper, 2024 · strength 0.15
- Akihito Machinaga · 1 shared paper, 2024 · strength 0.15
- Yuko Kitagawa · 1 shared paper, 2024 · strength 0.15
- Yuzo Kodama · 1 shared paper, 2024 · strength 0.15
- Hiromasa Takaishi · 2 shared papers, 2017–2018 · strength 0.14
- Paper Post-progression survival following second-line chemotherapy in patients with advanced pancreatic cancer previously tre… DOI 10.1007/s10637-018-0589-6↗
- Paper Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: meta-analysis of postp… DOI 10.1007/s00280-017-3263-3↗
- Akiyoshi Kasuga · 2 shared papers, 2017–2018 · strength 0.14
- Paper Post-progression survival following second-line chemotherapy in patients with advanced pancreatic cancer previously tre… DOI 10.1007/s10637-018-0589-6↗
- Paper Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: meta-analysis of postp… DOI 10.1007/s00280-017-3263-3↗
- Naohiro Okano · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.